Anti-inflammatory agents and monoHER protect against DOX-induced cardiotoxicity and accumulation of CML in mice

Cardiac damage is the major limiting factor for the clinical use of doxorubicin (DOX). Preclinical studies indicate that inflammatory effects may be involved in DOX-induced cardiotoxicity. N(ε)-(carboxymethyl) lysine (CML) is suggested to be generated subsequent to oxidative stress, including inflam...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Bruynzeel, A M E, Abou El Hassan, M A, Schalkwijk, C, Berkhof, J, Bast, A, Niessen, H W M, van der Vijgh, W J F
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2007
Matèries:
Translational Therapeutics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2360105/
https://ncbi.nlm.nih.gov/pubmed/17325706
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603640
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars